A carregar...
Systemic steroid treatment can desensitize the skin reaction due to regorafenib in a recurrence colorectal cancer patient
Oral intake of regorafenib has been shown to have survival benefits in patients with metastatic colorectal cancer progressing on standard therapies. However, because of adverse effects, the patients sometimes cannot continue treatment with regorafenib. Currently, there is no established supportive t...
Na minha lista:
| Publicado no: | Int Cancer Conf J |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Singapore
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6744540/ https://ncbi.nlm.nih.gov/pubmed/31559116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-019-00376-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|